Rhythm Pharmaceuticals, Inc. (RYTM)

NASDAQ: RYTM · Real-Time Price · USD

104.52

-0.22 (-0.21%)

Sep 2, 2026, 10:52 AM EDT - Market open

Rhythm Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	239.92	189.76	130.13	77.43	23.64	3.15
Revenue Growth	53.51%	45.83%	68.06%	227.56%	649.46%	-
Gross Profit	213.53	170.27	116.76	68.13	21.51	2.56
Operating Income	-200.63	-192.02	-173.1	-184.36	-179.16	-170.06
Net Income	-210.22	-201.92	-264.57	-184.68	-181.12	-69.61
Earnings Per Share	-3.12	-3.11	-4.34	-3.20	-3.47	-1.40
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Product Revenue, Net	239.92	194.77	130.13	77.43	16.88	3.15
License	-	-5.01	-	-	-	-
Revenue (Total)	239.92	189.76	130.13	77.43	23.64	3.15

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	330.9	388.95	320.57	275.85	333.29	294.86
Total Debt	109.78	112.17	113.75	107.4	77.75	2.55
Net Cash (Debt)	221.11	276.78	206.82	168.44	255.53	292.3
Net Cash Growth	24.89%	33.83%	22.78%	-34.08%	-12.58%	72.24%
Net Cash Per Share	3.28	4.26	3.39	2.92	4.90	5.89

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-105.35	-115.68	-113.88	-136.16	-173.43	-146
Capital Expenditures	-0.95	-0.95	-	-0.05	-0.28	-0.43
Free Cash Flow	-106.3	-116.63	-113.88	-136.2	-173.71	-146.44
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	89.00%	89.73%	89.73%	87.99%	90.98%	81.01%
Operating Margin	-83.62%	-101.19%	-133.03%	-238.10%	-757.92%	-5391.85%
Pretax Margin	-85.14%	-103.31%	-200.00%	-237.79%	-766.22%	-2207.10%
Profit Margin	-87.62%	-106.41%	-203.32%	-238.52%	-766.22%	-2207.10%
FCF Margin	-44.31%	-61.46%	-87.51%	-175.91%	-734.87%	-4642.90%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	30.00	37.65	26.44	35.09	69.42	159.06